Skip to search.
 TSX Up 0.20% TSX Ventures Down 0.29%

Abbott Laboratories (ABT)

-NYSE
48.94 0.00(0.00%) Jun 2, 4:01PM EDT
Add to Portfolio
Prev Close:48.94
Open:48.65
Bid:48.17 x 100
Ask:49.69 x 100
1y Target Est:51.19
Beta:1.3
Earnings Date:Jul 14 - Jul 20 (Est.)
Day's Range:48.32 - 49.19
52wk Range:39.28 - 49.43
Volume:5,138,146
Avg Vol (3m):4,748,840
Market Cap:72.86B
P/E (ttm):17.71
EPS (ttm):2.76
Div & Yield:0.96 (2.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABT 0.00%72.86B
NSRGYUp 0.30%N/A
RHHBYDown 0.43%N/A
TEVAUp 0.45%51.37B

Key Statistics

Forward P/E (1 yr):20.31
P/S (ttm):3.57
Ex-Dividend Date:13-Apr-15

Analysts

Annual EPS Est (Dec-15) :2.16
Quarterly EPS Est (Jun-15) :0.50
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback